Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
Ceribell (Nasdaq: CBLL) announced that CEO and Co-founder Jane Chao, Ph.D., will present at the William Blair 46th Annual Growth Stock Conference in Chicago.
Rhea-AI Summary
Ceribell (Nasdaq: CBLL) announced that CEO and Co-founder Jane Chao, Ph.D., will present at the William Blair 46th Annual Growth Stock Conference in Chicago.
The presentation is scheduled for Wednesday, June 3, 2026, at 9:20 a.m. PDT / 11:20 a.m. CDT, with a live and archived webcast available in the Investor Relations section of Ceribell’s website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – CBLL
On May 21, the first trading day after this news, CBLL closed 3.54% above the previous close.
Data tracked by StockTitan Argus for the May 21 session.
Key Figures
- Conference edition
- 46th Annual
- William Blair Growth Stock Conference
- Presentation date
- June 3, 2026
- William Blair 46th Annual Growth Stock Conference
- Presentation time PDT
- 9:20 a.m. PDT
- Scheduled presentation time
- Presentation time CDT
- 11:20 a.m. CDT
- Scheduled presentation time
Historical Context
-
Reported 29% revenue growth but wider net loss and higher operating expenses.
-
Announced participation in Bank of America Securities 2026 Health Care Conference.
-
Set timing for release of Q1 2026 results and accompanying conference call.
-
Reported strong 2025 revenue growth with higher operating expenses and net loss.
-
Outlined participation in March investor conferences with live and archived webcasts.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming William Blair 46th Annual Growth Stock Conference in Chicago. The presentation will take place on Wednesday, June 3, 2026, at 9:20 a.m. Pacific Daylight Time / 11:20 a.m. Central Daylight Time.
Event: William Blair 46th Annual Growth Stock Conference
Date: Wednesday, June 3, 2026
Time: 9:20 a.m. PDT / 11:20 a.m. CDT
A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
About CeriBell, Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute-care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared for detection of seizure and delirium in patients in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.
Investor Contact
Brian Johnston
Gilmartin Group
Investors@ceribell.com
Media Contact
Brian Price
Press@ceribell.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.